[go: up one dir, main page]

NZ566429A - Synthesis of renin inhibitors involving a cycloaddition reaction - Google Patents

Synthesis of renin inhibitors involving a cycloaddition reaction

Info

Publication number
NZ566429A
NZ566429A NZ566429A NZ56642906A NZ566429A NZ 566429 A NZ566429 A NZ 566429A NZ 566429 A NZ566429 A NZ 566429A NZ 56642906 A NZ56642906 A NZ 56642906A NZ 566429 A NZ566429 A NZ 566429A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
alkyl
salt
manufacture
Prior art date
Application number
NZ566429A
Other languages
English (en)
Inventor
Stuart John Mickel
Wolfgang Marterer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ566429(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NZ566429A publication Critical patent/NZ566429A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
NZ566429A 2005-09-28 2006-09-26 Synthesis of renin inhibitors involving a cycloaddition reaction NZ566429A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds
PCT/EP2006/009323 WO2007039183A1 (en) 2005-09-28 2006-09-26 Sythesis of renin inhibitors involving a cycloaddition reaction

Publications (1)

Publication Number Publication Date
NZ566429A true NZ566429A (en) 2010-10-29

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ566429A NZ566429A (en) 2005-09-28 2006-09-26 Synthesis of renin inhibitors involving a cycloaddition reaction

Country Status (27)

Country Link
US (2) US7973175B2 (es)
EP (2) EP2287153A1 (es)
JP (1) JP2009509990A (es)
KR (1) KR20080048042A (es)
CN (1) CN101273012A (es)
AR (1) AR057137A1 (es)
AT (1) ATE492533T1 (es)
AU (1) AU2006299097B2 (es)
BR (1) BRPI0616707A2 (es)
CA (1) CA2623495A1 (es)
DE (1) DE602006019114D1 (es)
EC (1) ECSP088319A (es)
ES (1) ES2358536T3 (es)
GB (1) GB0519764D0 (es)
GT (1) GT200600427A (es)
IL (1) IL189763A0 (es)
MA (1) MA29852B1 (es)
MY (1) MY143251A (es)
NO (1) NO20082005L (es)
NZ (1) NZ566429A (es)
PE (1) PE20070488A1 (es)
PL (1) PL1931629T3 (es)
PT (1) PT1931629E (es)
RU (1) RU2423348C2 (es)
TN (1) TNSN08142A1 (es)
TW (1) TW200730480A (es)
WO (1) WO2007039183A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
CN101774986B (zh) * 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
HU228526B1 (hu) 2000-07-05 2013-03-28 Speedel Pharma Ag Eljárás szubsztituált oktanoil-amid-származékok elõállítására, valamint az elõállításhoz alkalmazott közbensõ termékek
DE10116816A1 (de) 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2006299097A1 (en) 2007-04-12
ECSP088319A (es) 2008-04-28
JP2009509990A (ja) 2009-03-12
ES2358536T3 (es) 2011-05-11
AR057137A1 (es) 2007-11-21
MY143251A (en) 2011-04-15
RU2008116317A (ru) 2009-11-10
EP1931629B1 (en) 2010-12-22
GB0519764D0 (en) 2005-11-09
PE20070488A1 (es) 2007-06-13
GT200600427A (es) 2007-04-30
NO20082005L (no) 2008-06-24
MA29852B1 (fr) 2008-10-03
BRPI0616707A2 (pt) 2011-06-28
CN101273012A (zh) 2008-09-24
US20110230665A1 (en) 2011-09-22
WO2007039183A1 (en) 2007-04-12
AU2006299097B2 (en) 2010-11-04
US7973175B2 (en) 2011-07-05
EP2287153A1 (en) 2011-02-23
US20080255369A1 (en) 2008-10-16
PL1931629T3 (pl) 2011-05-31
DE602006019114D1 (de) 2011-02-03
CA2623495A1 (en) 2007-04-12
IL189763A0 (en) 2008-08-07
TW200730480A (en) 2007-08-16
PT1931629E (pt) 2011-03-09
TNSN08142A1 (en) 2009-07-14
RU2423348C2 (ru) 2011-07-10
ATE492533T1 (de) 2011-01-15
KR20080048042A (ko) 2008-05-30
EP1931629A1 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
JP6944473B2 (ja) 初期サクビトリル中間体のための新規な方法
US20110230665A1 (en) Synthesis of renin inhibitors involving a cycloaddition reaction
Fox et al. Asymmetric synthesis via electrophile-mediated cyclisations
JP2013028607A (ja) レニン阻害剤の製造方法
CN102378751B (zh) 用于制备二肽基肽酶-iv抑制剂和中间体的改进方法
DK2958893T3 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide
HK1150051A (en) Synthesis of renin inhibitors involving a cycloaddition reaction
Olszewska et al. Diastereoselective synthesis of 2-vinylpyrrolidines and 2-vinylpiperidines by the palladium-catalysed cyclization of amino-allylic carbonates containing a chiral protecting group
KR100576740B1 (ko) 스핑고신 전구체 화합물, 그 제조방법 및 이를 이용한 스핑고신
Zhang Improved synthesis of enantiopure sulfinimines (N-sulfinyl imines) and synthesis of alpha-and beta-amino acids via aziridines
WO2000053575A1 (en) SYNTHESIS OF α-AMINO-α',α'-DIHALOKETONES AND PROCESS FOR THE PREPARATION OF β-AMINO ACID DERIVATIVES BY THE USE OF THE SAME
WO2002048103A1 (en) Process for preparing active esters
JP2009046392A (ja) トリアザスマネン類、及び、その製造方法

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed